Navigation Links
Acanya(TM) Gel, a New Treatment for Moderate to Severe Acne, Launched by Coria Laboratories
Date:3/6/2009

ion in the skin in the form of an acne lesion. As a result, combination therapy targeting the multiple components of acne is now commonplace. In the past year, more than five million patients with acne in the U.S. sought treatment from a physician, resulting in over 17 million prescriptions filled, according to data from Verispan and IMS.

About Acanya Gel

Acanya Gel is the only FDA-approved fixed combination antibiotic and benzoyl peroxide (BPO) medication for once-daily treatment of both non-inflammatory and inflammatory lesions of acne. Formulated in an aqueous-based, alcohol-free gel, Acanya Gel was optimized to provide enhanced bioavailability of BPO, creating an effective and well tolerated product. In pivotal Phase III clinical trials, Acanya Gel showed superior efficacy to the vehicle gel and either individual active ingredient, while demonstrating excellent tolerability and very high patient satisfaction scores.

Acanya Gel was developed by Arcutis Pharmaceuticals, now a part of Coria Laboratories, a division of Valeant Pharmaceuticals International. Acanya Gel is protected by two U.S. Patents and has pending patent applications. More information about Acanya Gel can be obtained at www.AcanyaGel.com.

Indication and Important Safety Information for Acanya Gel

Acanya Gel (clindamycin phosphate 1.2% and benzoyl peroxide 2.5%) is indicated for the topical treatment of acne vulgaris in patients 12 years of age or older. In controlled clinical trials, the following application-site adverse reactions occurred in less than 0.2% of patients treated with Acanya Gel: application-site pain (0.1%), application-site exfoliation (0.1%), and application-site irritation (0.1%). Patients are advised to avoid applying in mouth, eyes, or nose or on lips, and to minimize sun exposure following the applicatio
'/>"/>

SOURCE Valeant Pharmaceuticals International
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
3. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
4. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
5. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
6. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
7. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
8. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
9. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
10. Many Heart Attack Patients Dont Get Best Emergency Treatment
11. New Study Proves That Minimally Invasive Aneurysm Treatment Yields Successful Long-Term Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... Dec. 14 Cardinal Health today announced that ... following events: ,, Goldman Sachs CEO Unplugged ... the Goldman Sachs Conference Center in New York. ... Jan. 12 at Noon EST at the Westin St. ... events, company executives will discuss Cardinal Health,s diverse products ...
(Date:12/14/2009)... Conn., Dec. 14 Zargis Medical Corp., ... SPDE ) and a spin-off from Siemens Corporate ... that it has begun selling its award-winning Zargis ... ,, Cardioscan and its accompanying Bluetooth®-enabled electronic stethoscope ... "2009 Innovation of the Year." ...
(Date:12/14/2009)... CARROLLTON, Ga., Dec. 14 /PRNewswire/ ... that its flagship integrated EHR, Prime Suite ... conditionally CCHIT Certified(®) 2011 Ambulatory EHR, additionally ... with optional Advanced Reporting. Greenway,s Prime Suite ... two new 2011 certification designations offered by ...
Breaking Medicine Technology:Cardinal Health Executives to Speak at Two Investor Events in January 2Zargis Cardioscan 'The Intelligent Stethoscope' Now Available on Amazon.com 2Greenway Medical Technologies' PrimeSuite 2011 Receives CCHIT 2011 Comprehensive Certification 2Greenway Medical Technologies' PrimeSuite 2011 Receives CCHIT 2011 Comprehensive Certification 3Greenway Medical Technologies' PrimeSuite 2011 Receives CCHIT 2011 Comprehensive Certification 4ERT Reports Third Quarter 2009 Results 5860 1ERT Reports Third Quarter 2009 Results 5860 2ERT Reports Third Quarter 2009 Results 5860 3ERT Reports Third Quarter 2009 Results 5860 4ERT Reports Third Quarter 2009 Results 5860 5ERT Reports Third Quarter 2009 Results 5860 6ERT Reports Third Quarter 2009 Results 5860 7ERT Reports Third Quarter 2009 Results 5860 8ERT Reports Third Quarter 2009 Results 5860 9ERT Reports Third Quarter 2009 Results 5860 10ERT Reports Third Quarter 2009 Results 5860 11ERT Reports Third Quarter 2009 Results 5860 12ERT Reports Third Quarter 2009 Results 5860 13NuVasive to Present at the Oppenheimer 20th Annual Healthcare Conference 5857 1NuVasive to Present at the Oppenheimer 20th Annual Healthcare Conference 5857 2NuVasive to Present at the Oppenheimer 20th Annual Healthcare Conference 5857 3Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 1Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 2Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 3Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 4Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 5Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 6Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 7Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 8
(Date:12/14/2009)... Dec. 14 Pepsi Bottling Group, ... of Kentucky are among the major employers that ... to help their employees make better decisions about ... employees a personalized summary of their families, use ... care. With this personalized information, employees can determine ...
(Date:12/14/2009)... Corporation (NYSE: HAE ) announced today ... to stop Fenwal Inc.,s continued patent infringement resulting ... using a modified separation chamber. Fenwal allegedly ... and the injunction entered by the Court prohibiting ... 1, 2010. According to statements made by ...
(Date:12/14/2009)... Dec. 14 Tough Enough To Wear Pink(TM) ... cancer, celebrated its fifth anniversary at the signature ... Wrangler National Finals Rodeo (Wrangler NFR) in Las ... rough-and-tumble rodeo cowboys, the support of the western ... sold-out crowd sported pink shirts, hats, bracelets and ...
(Date:12/14/2009)... up 900-Member Physician Staff , ... La Jolla, Calif. ... elected Marc Sedwitz, MD, as the new chief of staff of ... the 900-member physician team on Jan. 1, 2010. , , , ... staff liaison to Scripps La Jolla’s administrative staff and its board ...
(Date:12/14/2009)... of Tens of Thousands of New Chronic Hepatitis ... -- Legislation approved by Congress providing for federal ... helping to reduce tens of thousands of new ... United States, the National Viral Hepatitis Roundtable ... included in the FY 2010 Consolidated Appropriations bill ...
Breaking Medicine News(10 mins):Health News:Corporations, Universities and State Governments Deploy Thomson Reuters Solution to Improve Employees' Benefit Selection Process 2Health News:Haemonetics Files a New Legal Action to Stop Fenwal Inc.'s Continued Patent Infringement 2Health News:Haemonetics Files a New Legal Action to Stop Fenwal Inc.'s Continued Patent Infringement 3Health News:Tough Enough To Wear Pink(TM) Celebrates Fifth Anniversary 2Health News:Tough Enough To Wear Pink(TM) Celebrates Fifth Anniversary 3Health News:Tough Enough To Wear Pink(TM) Celebrates Fifth Anniversary 4Health News:New Chief of Staff Takes Over at Scripps Memorial Hospital La Jolla 2Health News:New Chief of Staff Takes Over at Scripps Memorial Hospital La Jolla 3Health News:NVHR Applauds Congressional Action to End Federal Ban on Funding Syringe Exchange 2
... An Indian-origin surgeon writer Atul Gawande has won a ... John D & Catherine T MacArthur Foundation//. ,Gawande, ... The New Yorker have made him one of the ... 25 new MacArthur Fellows for 2006 announced by the ...
... research done in Scotland revealed that smoking and drinking ... health education program// in classroom and encouragement of good ... MRC Social and Public Health Sciences Unit at Glasgow ... schools were questioned about their smoking and drinking habits. ...
... Maori are almost twice as likely to attempt suicide as ... generally than other New Zealanders. ,The survey conducted by ... on the prevalence of mental disorders among different ethnic groups ... people, including 2600 Maori. ,It was found that thirty ...
... has revealed that the prices of brand-name prescription drugs that ... the rate of inflation. ,However AARP's quarterly Rx Watchdog ... used by older Americans remain unchanged. ,AARP survey ... an increase in prices by 6.3 percent during the 12 ...
... in HIV/AIDS, owing to the indiscriminate use of injection ... has put forward a recommendation to encourage programs that ... a view to bringing down the rates of the ... countries in Eastern Europe, Asia, and Africa should begin ...
... The U.S Food and Drug Administration has approved a ... infections in post-surgical patients// including those whose immune systems ... now permitted for use, as a prevention of infections ... and Candida. This fungus easily penetrates the patients with ...
Other Medicine News:Health News:Indian American Surgeon Wins US "Genius" Award 2Health News:Drug Prices Rising Faster Than Inflation 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: